Results of Annual General Meeting of Shareholders Held May 31, 2018

Author's Avatar
Apr 12, 2019
Article's Main Image

SYDNEY, AUSTRALIA / ACCESSWIRE / June 5, 2018 / Parnell Pharmaceuticals Holdings Ltd (OTC PINK: PARNF – the Company), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and marketing innovative animal health solutions, today announced the results of its 2018 Annual General Meeting of Shareholders.